tradingkey.logo

Fractyl Health Announces Compelling 6-Month Randomized Remain-1 Midpoint Data Showing Durable Weight Maintenance With Revita® After Glp-1 Discontinuation

ReutersJan 29, 2026 12:22 PM

- Fractyl Health Inc GUTS.O:

  • FRACTYL HEALTH ANNOUNCES COMPELLING 6-MONTH RANDOMIZED REMAIN-1 MIDPOINT DATA SHOWING DURABLE WEIGHT MAINTENANCE WITH REVITA® AFTER GLP-1 DISCONTINUATION

  • FRACTYL HEALTH INC - REVITA-TREATED PATIENTS SHOW 4.5% WEIGHT REGAIN VERSUS 7.5% SHAM

  • FRACTYL HEALTH INC - REQUESTED FDA FEEDBACK ON REVITA DE NOVO PATHWAY

  • FRACTYL HEALTH INC: EXPECTS FDA FEEDBACK REGARDING POTENTIAL FOR USE OF DE NOVO PATHWAY IN Q2 OF 2026

  • FRACTYL HEALTH INC - REVITA SHOWS 4.2% WEIGHT REGAIN VERSUS 13.3% SHAM

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI